It has not been studied in children under the age of 6.Ītomoxetine was the first non-stimulant approved for treatment of ADHD in the United States by the Food and Drug Administration (FDA). Atomoxetine is not considered a controlled substance by the Drug Enforcement Agency (DEA). It is a selective norepinephrine reuptake inhibitor (SNRI) medicine. Atomoxetine (Brand Name: Strattera) is an effective and safe alternative to the stimulant medications most commonly used to treat attention deficit hyperactivity disorder (ADHD) in children ages 6-12, adolescents, and adults.
